Repositori institucional URV
Español Català English

TÍTOL:

Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia. - imarina:9453282

Autor/s de la URV:Martorell Bonet, Lourdes
Autor segons l'article:Morén C; Olivares-Berjaga D; Martínez-Pinteño A; Bioque M; Rodríguez N; Gassó P; Martorell L; Parellada E
Adreça de correu electrònic de l'autor:lourdes.martorell@urv.cat
Identificador de l'autor:0000-0003-4999-2197
Any de publicació de la revista:2025
Tipus de publicació:Journal Publications
Referència a l'article segons font original:International Journal Of Molecular Sciences. 26 (9):
Resum:Schizophrenia (SCZ) is a severe, chronic mental disorder of unknown etiology and limited therapeutic options. Bioenergetic deficits in the oxidative phosphorylation system (OXPHOS) during early postnatal brain development may underlie disrupted neuronal metabolism and synaptic signaling, contributing to the neurodevelopmental and behavioral disturbances observed in patients. This narrative review summarizes updated evidence linking mitochondrial-OXPHOS dysfunction to SCZ pathophysiology. The novelty lies in the focus on OXPHOS dysfunction at the enzymatic/functional level, rather than on genetic, transcriptional, or oxidative parameters. While complex I impairment has long been highlighted and proposed as a peripheral marker of the disease, recent studies also report alterations in other OXPHOS complexes and their precursors. These findings suggest that OXPHOS dysfunction is not isolated to a single enzymatic component but affects broader mitochondrial function, alongside oxidative stress, contributing to disease progression through mechanisms involving apoptosis, accelerated aging, and synaptic deterioration. OXPHOS dysfunction in both central and peripheral tissues further supports its relevance to SCZ. Overall, the literature points to mitochondrial OXPHOS abnormalities as a significant biological feature of SCZ. Whether these alterations are causal factors or consequences of disease processes remains unclear. Understanding OXPHOS dysregulation may open new avenues for targeted therapies.
DOI de l'article:10.3390/ijms26094415
Enllaç font original:https://www.mdpi.com/1422-0067/26/9/4415
Versió de l'article dipositat:info:eu-repo/semantics/publishedVersion
Accès a la llicència d'ús:https://creativecommons.org/licenses/by/3.0/es/
Departament:Medicina i Cirurgia
URL Document de llicència:https://repositori.urv.cat/ca/proteccio-de-dades/
Àrees temàtiques:Zootecnia / recursos pesqueiros
Spectroscopy
Saúde coletiva
Química
Psicología
Physical and theoretical chemistry
Organic chemistry
Odontología
Nutrição
Molecular biology
Medicine (miscellaneous)
Medicina veterinaria
Medicina iii
Medicina ii
Medicina i
Materiais
Interdisciplinar
Inorganic chemistry
Geociências
Farmacia
Engenharias iv
Engenharias ii
Engenharias i
Educação física
Computer science applications
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Ciências ambientais
Ciências agrárias i
Ciência de alimentos
Ciência da computação
Chemistry, multidisciplinary
Catalysis
Biotecnología
Biodiversidade
Biochemistry & molecular biology
Astronomia / física
Paraules clau:Schizophrenia
Oxphos
Oxidative stress
Oxidative phosphorylation
Mitochondria
Metabolism
Humans
Brain
Bioenergetics
Animals
Entitat:Universitat Rovira i Virgili
Data d'alta del registre:2025-05-17
Cerca el teu registre a:

Fitxers disponibles
FitxerDescripcióFormat
DocumentPrincipalDocumentPrincipalapplication/pdf


Informació

© 2011 Universitat Rovira i Virgili